Startup | December 10, 2021
Algorithmic Biologics receives CE mark for Tapestry platform
The platform’s technology works as a compression algorithm for molecular testing
The platform’s technology works as a compression algorithm for molecular testing
According to the companies’ preliminary data, a third dose provides a similar level of neutralizing antibodies to Omicron as is observed after two doses against wild-type and other variants that emerged before Omicron
Organised by the Indian Stroke Association, it has attracted over 800 doctors from India and overseas
_256_384.jpg)
Ind-Ra expects IPM revenue growth of over 12% yoy for FY22.
Data builds on promising signal published last week, underscoring the importance of sotrovimab for early treatment of COVID-19
Roche subsidiary TIB Molbiol rapidly developed additional testing options to differentiate mutations in the Omicron SARS-CoV-2 variant, as they continue to offer new and accurate detection solutions
The combination rapid antigen test quickly differentiates between SARS-CoV-2 and influenza viruses A and B infections, with results ready in less than 30 minutes, allowing informed decisions on patient and pandemic management decisions
These results demonstrate the potential benefits of heterologous boosting (mix-and-match). The article describing these results have been posted on medRxiv
The fund aims at investing in companies that extends human healthspan
Serum has a capacity of 250-275 million whereas Bharat Biotech has a capacity of 50-60 million
Subscribe To Our Newsletter & Stay Updated
